Data / Drug companies / Hydralazine hydrochloride
Hydralazine hydrochloride: 47 companies and 144 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Hydralazine hydrochloride is listed in the FDA National Drug Code Directory by 47 companies, with 144 products in commercial distribution. 144 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; injection; tablet, film coated, and the newest product started marketing on September 14, 2026.
The request: Get every company that lists hydralazine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 47
- Products
- 144
- Generic (ANDA) products
- 144 (100.0%)
- Application numbers
- 21
- Routes
- Oral, Intramuscular, Intravenous
- openFDA record search
- api.fda.gov
Companies that list hydralazine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Cardinal Health 107, LLC | 9 | tablet; injection | Generic drugs (ANDA) | September 14, 2026 |
| Bryant Ranch Prepack | 7 | tablet | Generic drugs (ANDA) | May 26, 2017 |
| Bryant Ranch Prepack | 7 | tablet | Generic drugs (ANDA) | May 26, 2017 |
| Remedyrepack Inc. | 7 | tablet; injection | Generic drugs (ANDA) | June 3, 2025 |
| A-S Medication Solutions | 6 | tablet | Generic drugs (ANDA) | May 26, 2017 |
| Bryant Ranch Prepack | 5 | tablet | Generic drugs (ANDA) | May 26, 2017 |
| Coupler LLC | 5 | tablet | Generic drugs (ANDA) | August 7, 2026 |
| Ascend Laboratories, LLC | 4 | tablet | Generic drugs (ANDA) | May 24, 2010 |
| Camber Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | January 1, 2010 |
| Chartwell RX, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | April 6, 2007 |
| Exelan Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | May 20, 2016 |
| Fresenius Kabi USA, LLC | 4 | injection | Generic drugs (ANDA) | January 31, 2011 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | August 2, 2023 |
| Macleods Pharmaceuticals Limited | 4 | tablet | Generic drugs (ANDA) | August 26, 2024 |
| Major Pharmaceuticals | 4 | tablet | Generic drugs (ANDA) | January 3, 2025 |
| Medical Purchasing Solutions, LLC | 4 | injection; injection, solution | Generic drugs (ANDA) | February 13, 2023 |
| Radha Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | March 4, 2021 |
| ScieGen Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | May 26, 2017 |
| Strides Pharma Science Limited | 4 | tablet | Generic drugs (ANDA) | June 30, 2022 |
| Teva Pharmaceuticals USA, Inc. | 4 | tablet | Generic drugs (ANDA) | September 30, 1990 |
| American Health Packaging | 3 | tablet | Generic drugs (ANDA) | September 15, 2024 |
| Aphena Pharma Solutions - Tennessee, LLC | 3 | tablet | Generic drugs (ANDA) | March 4, 2021 |
| Cadila Pharmaceuticals Limited | 3 | tablet | Generic drugs (ANDA) | December 29, 2015 |
| HF Acquisition Co LLC, DBA HealthFirst | 3 | injection; injection, solution | Generic drugs (ANDA) | December 9, 2019 |
| Modavar Pharmaceuticals LLC | 3 | tablet | Generic drugs (ANDA) | December 29, 2015 |
| Mylan Institutional Inc. | 3 | tablet | Generic drugs (ANDA) | December 26, 2007 |
| NuCare Pharmaceuticals,Inc. | 3 | tablet | Generic drugs (ANDA) | January 1, 2010 |
| Safecor Health, LLC | 3 | tablet | Generic drugs (ANDA) | March 6, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | May 20, 2016 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | June 30, 2013 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | August 2, 2023 |
| American Regent, Inc. | 1 | injection, solution | Generic drugs (ANDA) | June 30, 1997 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | September 30, 1990 |
| Baxter Healthcare Corporation | 1 | injection | Generic drugs (ANDA) | July 17, 2025 |
| Civica, Inc. | 1 | injection, solution | Generic drugs (ANDA) | October 29, 2020 |
| Eugia US LLC | 1 | injection | Generic drugs (ANDA) | February 13, 2023 |
| Henry Schein, Inc. | 1 | injection | Generic drugs (ANDA) | April 10, 2025 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, solution | Generic drugs (ANDA) | December 18, 2020 |
| Meitheal Pharmaceuticals Inc. | 1 | injection | Generic drugs (ANDA) | June 2, 2025 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet | Generic drugs (ANDA) | January 1, 2010 |
| Navinta LLC | 1 | injection | Generic drugs (ANDA) | November 25, 2025 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | February 15, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | April 6, 2007 |
| Preferred Pharmaceuticals Inc. | 1 | tablet | Generic drugs (ANDA) | October 5, 2021 |
| ProPharma Distribution | 1 | injection | Generic drugs (ANDA) | January 31, 2011 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | April 6, 2007 |
| Zydus Pharmaceuticals USA Inc. | 1 | injection | Generic drugs (ANDA) | April 28, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 114 | 79.2% |
| Injection | 19 | 13.2% |
| Tablet, film coated | 6 | 4.2% |
| Injection, solution | 5 | 3.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 144 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Arteriolar Vasodilator | 144 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.